Algorae Pharmaceuticals Limited has released a press release.
LCT commences AI-116 pre clinical studies
Filed with ASX ·
6ix hasn’t read this filing yet.
Algorae Pharmaceuticals Limited on 6ix
Earlier from Algorae Pharmaceuticals
- Quarterly Activities/Appendix 4C Cash Flow Report
- Patent application over AI-116 for Dementia filed
- LCT Announces Shortfall Completion Notice
- Rights Issue Prospectus
- APeT Cleansing Announcement
Later from Algorae Pharmaceuticals
- Quarterly Activities/Appendix 5B Cash Flow Report
- CSIRO Grant for Artificial Intelligence Platform
- Addendum to September Quarterly Report
- 1AI commences AI-168 pre-clinical studies
- Algorae to list existing Option series on ASX
Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.
Follow Algorae Pharmaceuticals